Results 151 to 160 of about 5,020 (198)

Shuffling the JAKs: playing a new card in chronic GVHD. [PDF]

Blood Adv
Boiko JR, Carpenter PA.
europepmc   +1 more source

Intermittent and Short-Term Empirical Ruxolitinib Regimen for Steroid-Refractory Flareups of Fibrodysplasia Ossificans Progressiva. [PDF]

Pharmacol Res Perspect
Chen RL, Yang TH, Wang YH, Shaw JJ, Chen LY.   +4 more
europepmc   +1 more source

Understanding DMG: current treatment options and prospective solutions using nanoparticles. [PDF]

Drug Deliv Transl Res
Mohamed A, Lyzlov A, Prasad R, Moats RA, Krieger MD, Desai VR, Margol AS, Chiarelli PA, Upreti M.   +8 more
europepmc   +1 more source

Inhibition of astrocyte BMP signaling alleviates neuroinflammation in experimental models of Parkinson's disease. [PDF]

Cell Death Discov
Li Y, Li Y, Hao J, Wang W, Su Z, Tian X, Wang H, Liu Q, Gao J, Geng D, Wang L.   +10 more
europepmc   +1 more source

An inducible knock-in mouse model of fibrodysplasia ossificans progressiva shows spontaneous formation of heterotopic ossification. [PDF]

JBMR Plus
Chakkalakal SA, Großmann NZ, Mejías Rivera L, Roberts DW, Pacifici M, Mourkioti F, Shore EM.   +6 more
europepmc   +1 more source

Single-cell and bulk transcriptomic analyses uncover immune subtypes associated with programmed cell death features in intrahepatic cholangiocarcinoma. [PDF]

Sci Rep
Zhang T, Dou D, Liu Q, Xu D, Wang T, Liu R, Lu D, Zhao X, Wang S, Zhang H.   +9 more
europepmc   +1 more source

Advancements in mechanisms and drug treatments for fibrodysplasia ossificans progressiva. [PDF]

J Zhejiang Univ Sci B
Zhou Y, Shi C, Sun H.
europepmc   +1 more source

Reirradiation for diffuse intrinsic pontine glioma in an upper middle-income country: does full dose improve outcomes? [PDF]

Childs Nerv Syst
Dassi N, Figueiredo MLS, Gamba FT, da Costa MDS, Dos Santos Torquato AC, Rodrigues JB, de Souza Filho RM, Cavalheiro S, Dastoli PA, Silva FA, Moraes CVB, de Toledo SRC, Da Silva NS, Chen MJ, Cappellano AM.   +14 more
europepmc   +1 more source

PI3Kα inhibition blocks osteochondroprogenitor specification and the hyper-inflammatory response to prevent heterotopic ossification. [PDF]

Elife
Valer JA, Deber A, Wits M, Pimenta-Lope C, Goumans MJ, Rosa JL, Sánchez-Duffhues G, Ventura F.   +7 more
europepmc   +1 more source